Female UrologyComparison of Economic Impact of Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Interstitial Cystitis/Painful Bladder Syndrome
Section snippets
Subjects
The sample consisted of 43 women and 62 men from the Northwestern University outpatient urology clinic. The patients were identified and recruited according to a physician diagnosis of IC/PBS for the women and CP/CPPS for the men. The patients were presented with a resource use questionnaire while waiting in the clinic or were mailed a questionnaire after being identified in the clinic setting. The institutional review board approved the study.
Questionnaire Content
The questionnaire included demographic information
Demographics
The demographic characteristics are listed in Table 1. The mean age of the male and female cohorts was identical (51 years). Most subjects were white and college educated. An annual household income >$50 000 was reported by 65% of the women and 73% of the men.
Use of Medical Services
A summary of outpatient visits and procedures related to IC/PBS and CP/CPPS for the preceding 3 months is provided in Table 2. Of the 43 women and 62 men, 30 (70%) and 45 (73%) reported ≥1 outpatient visit related to IC/PBS or CP/CPPS,
Comment
Approximately 80% of patients with either CP/CPPS or IC/PBS reported direct medical costs in the preceding 3 months that were attributed to their pelvic pain symptoms. The direct costs associated with IC/PBS were slightly greater than those for CP/CPPS across all examined categories. Using Medicare rates, the mean yearly cost for IC/PBS was $3631 per person and for CP/CPPS was $3017 per person. However, the use of non-Medicare rates might more accurately reflect the true costs, given that a
Conclusions
Both CP/CPPS and IC/PBS have substantial direct and indirect costs, with indirect costs accounting for a large proportion of the total. Regardless of the cost mechanism used (Medicare or non-Medicare), the direct costs of these conditions are greater than the mean yearly costs reported for many other chronic pain conditions. The substantial costs associated with CP/CPPS and IC/PBS support ongoing efforts to educate physicians about these conditions and to identify effective treatments.
References (13)
- et al.
Healthcare use and costs of primary and secondary care patients with prostatitis
Urology
(2004) - et al.
Costs of interstitial cystitis in a managed care population
Urology
(2008) - et al.
Urologic diseases in America project: interstitial cystitis and painful bladder syndrome
J Urol
(2007) - et al.
The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure
J Urol
(1999) - et al.
The Interstitial Cystitis Symptom Index and problem index
Urology
(1997) - et al.
Interstitial cystitis: cost, treatment and co-morbidities in an employed population
Pharmacoeconomics
(2006)
Cited by (53)
A Systematic Review of the Cost of Chronic Pelvic Pain in Women
2022, Journal of Obstetrics and Gynaecology CanadaCitation Excerpt :In one of these studies, the sums of healthcare costs and indirect costs were combined.5 In another, the sums of healthcare, out-of-pocket, and indirect costs were combined.8 The studies reporting combined costs are summarized in the Table.
IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model
2018, CytokineCitation Excerpt :The reduction of QOL results from unrelenting pain, sexual dysfunction, and urinary urgency, and frequency, necessitating frequent trips to the bathroom, sometimes as often as every 10–15 min throughout the day and night [1,2]. The direct and indirect costs for U.S. IC/PBS patients and their families, including increased medical expenses and decreased work productivity, is estimated to be on the order of $21.1 billion dollars annually [3]. IC/PBS is a chronic bladder disorder with many patients lacking effective treatment options [4,5].
Predictors of pain, urinary symptoms and quality of life in patients with chronic pelvic pain syndrome (CPPS): A prospective 12-month follow-up study
2018, Journal of Psychosomatic ResearchImaging in Urology
2018, Imaging in UrologyAnorectal and Pelvic Pain
2016, Mayo Clinic ProceedingsCitation Excerpt :Among a cohort of 239 patients in a managed care setting, the mean cost of IC was $6614, including $1572 for prescription medications and $3463 for outpatient medical services.82,83 Among women with IC/BPS, 19% lost wages, with a mean annual cost of $4216.83 Current concepts derived largely from in vitro and animal studies support the following framework (Figure 1).
This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant U01 DK060177.